TY - JOUR
T1 - Acute Hemodynamic Compromise After Transcatheter Aortic Valve Replacement Due to Dynamic Left Ventricle Obstruction
T2 - A Systematic Review
AU - Barzallo, Diego
AU - Torrado, Juan
AU - Benites-Moya, Cesar Joel
AU - Sturla, Matteo
AU - Echarte-Morales, Julio
AU - Scotti, Andrea
AU - Kharawala, Amrin
AU - Terre, Juan A.
AU - Sugiura, Tadahisa
AU - Wiley, Jose
AU - Goldberg, Ythan
AU - Latib, Azeem
N1 - Publisher Copyright:
© 2023 Elsevier Inc.
PY - 2024/3/1
Y1 - 2024/3/1
N2 - Acute hemodynamic compromise after transcatheter aortic valve replacement (TAVR) because of dynamic left ventricle (LV) obstruction (LVO), also known as suicide LV, is an infrequent but severe complication of TAVR that is poorly defined in previous studies. Understanding this complication is essential for its prompt diagnosis and optimal treatment. We conducted a systematic literature review using PubMed, Embase, Web of Science, and Medline databases for studies describing acute hemodynamic compromise after TAVR because of dynamic LVO or suicide LV. Each study was reviewed by 2 authors individually for eligibility, and a third author resolved disagreements. From a total of 506 studies, 25 publications were considered for the final analysis. The majority of patients with this condition were women demonstrating a hypertrophic septum, a small ventricle, and hyperdynamic contractility on pre-TAVR echocardiographic assessment. An intraventricular gradient before TAVR was found in half of the cases. Acute hemodynamic compromise after TAVR because of dynamic LVO manifested mainly as significant hypotension and occurred most often immediately after valve deployment. The LV outflow tract was the most common site of obstruction. Advanced therapies were required in nearly 65% of the cases. In conclusion, acute hemodynamic compromise after TAVR because of dynamic LVO occurred almost invariably in women. Echocardiography before TAVR may offer essential information to anticipate this complication. LV outflow tract obstruction appears to carry the highest risk of developing this phenomenon. Advanced therapies should be promptly considered as a bailout strategy in patients with hemodynamic collapse refractory to medical therapy.
AB - Acute hemodynamic compromise after transcatheter aortic valve replacement (TAVR) because of dynamic left ventricle (LV) obstruction (LVO), also known as suicide LV, is an infrequent but severe complication of TAVR that is poorly defined in previous studies. Understanding this complication is essential for its prompt diagnosis and optimal treatment. We conducted a systematic literature review using PubMed, Embase, Web of Science, and Medline databases for studies describing acute hemodynamic compromise after TAVR because of dynamic LVO or suicide LV. Each study was reviewed by 2 authors individually for eligibility, and a third author resolved disagreements. From a total of 506 studies, 25 publications were considered for the final analysis. The majority of patients with this condition were women demonstrating a hypertrophic septum, a small ventricle, and hyperdynamic contractility on pre-TAVR echocardiographic assessment. An intraventricular gradient before TAVR was found in half of the cases. Acute hemodynamic compromise after TAVR because of dynamic LVO manifested mainly as significant hypotension and occurred most often immediately after valve deployment. The LV outflow tract was the most common site of obstruction. Advanced therapies were required in nearly 65% of the cases. In conclusion, acute hemodynamic compromise after TAVR because of dynamic LVO occurred almost invariably in women. Echocardiography before TAVR may offer essential information to anticipate this complication. LV outflow tract obstruction appears to carry the highest risk of developing this phenomenon. Advanced therapies should be promptly considered as a bailout strategy in patients with hemodynamic collapse refractory to medical therapy.
KW - TAVR complications
KW - dynamic left ventricular obstruction
KW - suicide left ventricle
KW - systematic review
UR - http://www.scopus.com/inward/record.url?scp=85183849165&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85183849165&partnerID=8YFLogxK
U2 - 10.1016/j.amjcard.2023.12.005
DO - 10.1016/j.amjcard.2023.12.005
M3 - Article
C2 - 38103763
AN - SCOPUS:85183849165
SN - 0002-9149
VL - 214
SP - 125
EP - 135
JO - American Journal of Cardiology
JF - American Journal of Cardiology
ER -